Last reviewed · How we verify

Nifedipine soft gelatine capsules

Reig Jofre Group · Phase 1 active Small molecule

Nifedipine soft gelatine capsules is a Small molecule drug developed by Reig Jofre Group. It is currently in Phase 1 development. Also known as: Adalat.

At a glance

Generic nameNifedipine soft gelatine capsules
Also known asAdalat
SponsorReig Jofre Group
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Nifedipine soft gelatine capsules

What is Nifedipine soft gelatine capsules?

Nifedipine soft gelatine capsules is a Small molecule drug developed by Reig Jofre Group.

Who makes Nifedipine soft gelatine capsules?

Nifedipine soft gelatine capsules is developed by Reig Jofre Group (see full Reig Jofre Group pipeline at /company/reig-jofre-group).

Is Nifedipine soft gelatine capsules also known as anything else?

Nifedipine soft gelatine capsules is also known as Adalat.

What development phase is Nifedipine soft gelatine capsules in?

Nifedipine soft gelatine capsules is in Phase 1.

Related